Title: Lambert–Eaton myasthenic syndrome
Long Title: IUPAC Gold Book - Lambert–Eaton myasthenic syndrome
DOI: 10.1351/goldbook.13371
Status: current

Definition
Paraneoplastic neurological disorder associated with small-cell lung cancer and caused by autoantibodies against voltage-gated calcium channels.

Related Terms
- Paraneoplastic: https://goldbook.iupac.org/terms/view/13535
- autoantibodies: https://goldbook.iupac.org/terms/view/12913

Source
- PAC, 2012, 84, 1113. 'IUPAC glossary of terms used in immunotoxicology (IUPAC Recommendations 2012)' on page 1200 (https://doi.org/10.1351/PAC-REC-11-06-03)

Other Outputs
- html: https://goldbook.iupac.org/terms/view/13371/html
- json: https://goldbook.iupac.org/terms/view/13371/json
- xml: https://goldbook.iupac.org/terms/view/13371/xml

Citation: Citation: 'Lambert–Eaton myasthenic syndrome' in IUPAC Compendium of Chemical Terminology, 5th ed. International Union of Pure and Applied Chemistry; 2025. Online version 5.0.0, 2025. 10.1351/goldbook.13371
License: The IUPAC Gold Book is licensed under Creative Commons Attribution-ShareAlike CC BY-SA 4.0 International (https://creativecommons.org/licenses/by-sa/4.0/) for individual terms.
Collection: If you are interested in licensing the Gold Book for commercial use, please contact the IUPAC Executive Director at executivedirector@iupac.org .
Disclaimer: The International Union of Pure and Applied Chemistry (IUPAC) is continuously reviewing and, where needed, updating terms in the Compendium of Chemical Terminology (the IUPAC Gold Book). Users of these terms are encouraged to include the version of a term with its use and to check regularly for updates to term definitions that you are using.
Accessed: 2026-06-30T02:48:45+00:00